Effect of valproate and felbamate on carbamazepine and its metabolites in epileptic children

Journal of Epilepsy

Volumn 10, Issue 1, 1997, Pages 37-41

  Liu, Hua ^a,c   Delgado, Mauricio R ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

Author keywords

Carbamazepine; Carbamazepine 10,11 epoxide; Drug interactions; Felbamate; Valproate

Indexed keywords

CARBAMAZEPINE; FELBAMATE; VALPROIC ACID;

ADOLESCENT; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TRANSFORMATION; EPILEPSY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030944135     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(96)00068-0     Document Type: Article

References (21)

1. 1. Liu H, Delgado MR, Browne RH. Interactions of valproic acid with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children. Clin Neuropharmacol 1995;18:1-12.
2. 2. Pisani F, Fazio A, Oteri G, et al. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Epilepsia 1986;27:548-52.
3. 3. Pitlick WH, Levy RH. Carbamazepine interactions with other drugs. In: Levy RH, Mattson RH, Meldrum B, Penry JK, Dreifuss FE, eds. Antiepileptic drugs, 3rd ed. New York: Raven Press, 1989:521-31.
4. 4. Liu H, Delgado MR. Improved therapeutic monitoring of drug interactions in epileptic children using carbamazepine polytherapy. Ther Drug Monit 1994;16:132-8.
5. 5. Liu H, Delgado MR. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children. Epilepsy Res 1994;17:257-69.
6. 6. Wilder BJ, Willmore LJ, Bruni J, Villarreal HJ. Valproic acid: interaction with other anticonvulsant drugs. Neurology 1978;28:892-6.
7. 7. Ramsay RE, McManus DQ, Guterman A, et al. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. Ther Drug Monit 1990;12:235-41.
8. 8. Wang RB, Liu LT, Yiu CH, Chang TY. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite. Chin Med J (Taipei) 1990;45:222-32.
9. 9. Sunaoshi W, Miura H, Takanashi S, Shirai H, Hosoda N. Influence of concurrent administration of sodium valproate on the plasma concentrations of carbamazepine and its epoxide and diol metabolites. Jpn J Psychiatr Neurol 1991;45: 474-7.
10. 10. Elyas AA, Patsalos PN, Agbato OA, Brett EM, Lascelles PT. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10,11-epoxide in serum of children with epilepsy. Ther Drug Monit 1986;8:288-92.
11. 11. Leppik IE, Dreifuss FE, Pledger GW, et al. Felbamate for partial seizures: results of a controlled clinical trial. Neurology 1991;41:1785-9.
12. 12. Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993;43:688-92.
13. 13. Ritter ET, Leppik IE, Dreifuss FE, et al. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
14. 14. Fuerst RH, Graves NM, Leppik IE, et al. Felbamate increases phenytoin but decreases carbamazepine concentrations. Epilepsia 1988;29:488-91.
15. 15. Albani F, Theodore WH, Washington P, et al. Effect of felbamate on plasma levels of carbamazepine and its metabolites. Epilepsia 1991;32:130-2.
16. 16. Wagner ML, Remmel RP, Graves NM, Leppik IE. Effect of felbamate on carbamazepine and its major metabolites. Clin Pharmacol Ther 1993;53:536-43.
17. 17. Liu H, Delgado MR, Forman LJ, et al. Simultaneous determination of carbamazepine, phenytoin, phenobarbital, primidone and their principal metabolites by HPLC with photodiode-array detection. J Chromatogr 1993;616:105-15.
18. 18. Romanyshyn LA, Wichmann JK, Kucharczyk N, et al. Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high-performance liquid chromatography. Ther Drug Monitor 1994;16:90-9.
19. 19. Pisani F, Caputo M, Fazio A, et al. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study. Epilepsia 1990;31: 339-42.
20. 20. Kerr BM, Levy RH. Carbamazepine epoxide. In: Levy RH, Mattson RH, Meldrum B, Penry JK, Dreifuss FE, eds. Antiepileptic drugs, 3rd ed. New York: Raven Press, 1989:505-20.
21. 21. Brodie MJ, Forrest G, Rapeport WG. Carbamazepine 10,11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Br J Clin Pharmacol 1983;16:747-50.